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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
















 3 out of 99 asymptomatic 
people recruited from a clinical 
laboratory in the general 
population in May, 2020 in 
Addis Ababa tested positive 
for SARS-CoV-2 IgG 
 Plausible population 
prevalence values range from 
1.0 to 8% when taking into 
account pre-test probability 
and the sampling scheme 
 Results suggest that the large 
majority of the general 
population in Addis Ababa are 


























 This study summarises the 
level of risk reduction 
practices about C19 through 
systematic review 
 Lack of C19-relted 
knowledge, positive 
perceptions, and preventive 
practices was detected and 
seems widespread 
 Evidence-based practices on 
risk communication and 
raising awareness should be 
planned by local governments 
in collaboration with 
healthcare organisations 
 Educational initiatives for 
HCWs to wear a face mask 
and practicing hand hygiene 





























 LMICs, regional and 
national estimates of 
mortality for HCWs, 
cost-effectiveness and 
return on investment 
are presented  
 Wide-scale 
procurement and 
distribution of PPE for 
LMICs is essential to 
prevent widespread 
HCW morbidity and 
mortality. It is cost-
effective and yields a 
large downstream 





Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
July 2020 Africa’s COVID-19 health technologies’ 
watershed moment 
The Lancet 
Digital Health | 
News 
Paul Adepoju 
24.06.2020 Globalisation in the time of COVID-19: 
repositioning Africa to meet the immediate 
and remote challenges 
Globalization 
and Health | 
Commentary 
Sanni Yaya et cl 
24.06.2020 Commercial influence and covid-19 BMJ | Editorial  
24.06.2020 From Ebola to COVID-19: How Uganda 
can adapt its response to the current crisis 
Health Policy 
and Planning 





23.06.2020 Beyond COVID-19 (coronavirus): What 
will be the new normal for health systems 
and universal health coverage? 






23.06.2020 Besides population age structure, health 
and other demographic factors can 
contribute to understanding the COVID-19 
burden 
PNAS | Letter Marilia R. 
Nepomyceno et 
al. 
23.06.2020 In poor countries, many Covid-19 patients 
are desperate for oxygen 
NY Times | 
Global Health 
News 
Donald G. McNeil 
23.06.2020 The colliding epidemics of COVID-19, 
Ebola, and measles in the Democratic 
Republic of the Congo 
The Lancet 
Global Health | 
Comment 
Jean B Nachega 
et al 
4 
23.06.2020 COVID-19 scientific and public health 
policy update (23 June 2020) 
Africa CDC  
22.06.2020 COVID-19 & violence against women and 
children: what have we learned to far? 
CGD | Notes Amber Peterman 
Megan O’Donnell 
Tia Palermo 
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  Sierra 
Leone 





US NIH  Our World 
in Data: C19 
Testing 




Our World in 
Data 
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Global 5050 









  US  COVID-19 
Primer 




     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 




              
C19 Resource Hubs 









  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 







  IDA 
6 






















g in low 
resource 
settings 
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Health 
    





Oxford Centre for 
Evidence-based 
Medicine 
    




 HEART     
UNESCO   NEJM  UKRI     
7 
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 




  SSRN 
(Preprints)  
      












      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 





GISAID           
Online learning & events 








collateral effects of 
COVID-19 
Online event 1h 30 CGD 
13 July 3:00 





by Dr Muhammad 
Pate, Global Director 
for Health, Nutrition 
and Population at the 
World Bank Group 




UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 








role in COVID-19 
vaccine development 
and access 














Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 




WHO Academy and 
WHO Info mobile 
applications 





Modelling and Policy 
Online 
learning 













Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed 
Kelley 




5 hours Johns Hopkins 






5 sessions 1h 30 International Initiative 











online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 




































































of Edinburgh & Royal 
College of Physicians 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
